Archives: Speakers

Janet has extensive experience in strategic leadership positions in the UK health research and health data research environment. As Executive Director of Innovation and Research Policy at the Association of the British Pharmaceutical Industry (ABPI), Janet is responsible for influencing Government policy to make the UK a globally attractive destination to discover and develop new medicines and vaccines. Janet was initially appointed to the ABPI as Director of Health Data and Digital Policy. Prior to joining the ABPI, Janet was the Industrial Strategy Challenge Fund Director for Data to Early Diagnosis and Precision Medicine at Innovate UK, where she oversaw a broad portfolio of investments in genomics, health data, AI, medical imaging and digital pathology. In her previous role as an Executive Director at the Medicines and Healthcare Products Regulatory Agency (MHRA), Janet led the Clinical Practice Research Datalink (CPRD). CPRD is the UK’s largest dedicated health data research service, providing research data services to industry, academia and regulators worldwide. Janet’s previous roles include Head of Population Health and Health Informatics at the Medical Research Council and Deputy Chief Executive of the UK Clinical Research Collaboration. Janet’s scientific background is in gene regulation.

Fiona is an experienced Clinical research Professional who has 25+ years of extensive experience in different roles of Clinical Trial Operations. Starting her career as an Oncology Nurse she moved into Clinical Research to support the development of Clinical Trial delivery at the Leicester Royal Infirmary which then became part of the National Cancer Research Network. Moving her career forward she has undertaken a variety of roles, in CROs, Pharma and Medical Device companies concentrating on the building of trial Operation Services.

In her current role,  Country Head ( UK), Study and Site Operations,  within Novartis Fiona is accountable for all country clinical operations and has a responsibility to drive the strategic direction of the study and site operations department. She  manages a team of accomplished leaders to increase the contribution that Novartis can make within the Clinical Trial landscape.

Throughout her career Fiona has always had a passion for people leadership and applies this in her management and leadership style.

Professor Andrew Ustianowski is a Consultant Physician in Infectious Diseases at the Regional Infection Unit, North Manchester General Hospital, UK, and from April 2024 the Network Director for the NW Regional Research Delivery Network, National Institute of Health Research (NIHR). Other roles include: the joint National Specialty Lead for Infection (NIHR); co-Clinical Director for the Greater Manchester Clinical Research Network; Clinical Lead for the Manchester Academic Health Science Centre; National Clinical Lead for the UK NIHR COVID Vaccine Research Programme; and joint National Clinical Lead for the UK’s Vaccine Innovation Pathway. He has been UK chief investigator on multiple COVID, HIV and other studies and PI on >100 other trials.

Prof Ustianowski graduated from Guy’s Hospital, London, UK and subsequently trained in Infectious Diseases, Tropical Medicine, HIV and General Medicine in the London region

PhD in Natural Sciences

20 years in the Pharmaceutical Industry: CRO and Pharma

5 years Sales for Temp and Condition Monitoring solutions

Strong Science and Clinical Trials Background

Meets and exceeds clients expectations, consultant and solution provider